The health of the younger generation is one of the main care of health care worldwide. This is not surprising, t.To. In developed countries, the population will grow rapidly, and fertility rates are low. This is especially true for European states. At the end of June, the next, the fifth European Congress of Pediatrics (Europaediatrics-2011) was held in Vienna (Europaediatrics-2011), on which leading experts were able to exchange experiences of solving key problems in the field of child health. Do not be ignited by doctors and infectious diseases, including respiratory infections.
Content
Talking once again about the relevance of the prevention and treatment of acute respiratory infections and influenza no sense, and specialists and ordinary citizens are well aware of those consequences that can be presented «cold», If it takes to it without due attention. Obviously, at such a representative forum, and more than two thousand specialists from 93 countries of the world took part in his work this year, could not get around the attention of such an important topic. A significant contribution to the work of the forum was made by the Russian delegation, represented by two hundreds of specialists from various profiles.
One of the reports presented on the forum and published in the journal of the Cochrane Community «Cochrane Review Journal «Evidence-based Child Health», was prepared on the basis of the results of the study conducted by the Russian State Medical University under the direction of Professor of the Department of Faculty Pediatrics.M.N. Tamara Kazyukova.
Study «Clinical and epidemiological assessment of the effectiveness of otilloccine in the framework of the family prevention of respiratory infections during the surgery of respiratory morbidity 2009-2010.» 17 weeks lasted (from November 1, 2009. until March 1, 2010.), 376 people took part in it Of 72 families. The main group was 36 families (n = 164), all members of which were made preventive otlococcinum 1 tube 1 time per week. In the second group also included 36 families (n = 162), whose members used any other means of the prevention of ARVI without a certain system, sometimes – at the first symptoms of Ori.
The results represented by Tamara Kazyukov turned out to be remarkable. During the epidseason, the main group fell ill 21 (12.8%), which was almost three times lower than in the second group, where 62 (38%) of a person became ill. In addition, in the main group there was not a single case of influenza case, while in the second group in 7 cases (4.3%) was diagnosed with influenza A (N1H1) 2009, revealed laboratory. It should be noted that there were not a single person vaccinated against influenza among the fallen flu.
It was also noted that the reception of the drug allowed minimizing the development of complications in the event of a disease and remained safe with long-term use. In particular, there were no adverse reactions in children with lactase deficiency.
The results of the study showed the clinical efficacy of the otilloccinum to prevent the family morbidity of the flu and other ARVI in the epidemiological season of recipient morbidity. During the reception of the drug, not a single case of side effects or allergic reactions was recorded, although in 38.4% of cases, the reception was combined with the reception of other drugs. Thus, the safety of long-term admission of the drug in persons aged from 3.5 months. up to 76 years old and its combination with other prepartes.
«Conclusions of this observation have a high practical value for primary registry doctors. We have gained reliable confirmation of the effectiveness of collective systematic and targeted prevention. Based on the main parameters of preventive measures – systematic, duration and opportunities for all family members from children to older people – Basic drug requirements for prevention are becoming obvious.
For us, this is very important, since in Russia neither the tradition of preventing respiratory diseases has not yet passed, and the chemotherapy remains a basic dominant treatment facility, - emphasizes Tamara Kazyukova. It is known that today in Europe many doctors begin to pay attention to the fact that the use of chemically synthesized drugs is fraught with a large number of adverse reactions, the development of resistance and T.D., Notes an expert. The fact that the results of the observation were consonant with global trends, allow us to implement them with confidence in practice».
